News

The investigational oral treatment would be used in addition to insulin therapy to improve blood sugar control in adults with type 1 diabetes. Sanofi development global head and

The Singapore Economic Development Board is supporting the development of new facility, which is the firm’s first abroad site in Asia and second site outside of China. The

The partnership uses Evotec's phenotypic screening capabilities and compound libraries. According to the terms of the long-term drug discovery and development partnership, Celgene will pay an upfront payment of

The patents, among other aspects, broadly cover compositions of matter of the inflammation-targeting microfiber materials with embedded molecules of interest. The platform is being evaluated for use across

Juluca is a two-drug regimen of ViiV Healthcare’s dolutegravir and Janssen Sciences Ireland’s rilpivirine. The drug received approval to treat HIV-1 infection in adults, who are virologically suppressed (HIV-1

The clinical equivalence study is being conducted in 24 healthy subjects in a double-blind, randomised, parallel group protocol to evaluate the interchangeability between Q-Octreotide and the reference product,

The approval for the thrombopoietin (TPO) receptor agonist is for adult patients who are scheduled to go through a medical or dental procedure. The regulator said Doptelet is the

The company reported positive results from phase III Haven 3 study assessing Hemlibra prophylaxis administered every week or every two weeks in people with haemophilia A without factor

Hyperkalemia is a serious condition characterized by high levels of potassium in the blood (greater than 5.0 mEq/L). The risk of hyperkalemia increases significantly for patients with chronic